<p>Data is represented as mean ± SD (n = 6 per group). Fasting plasma glucose (ANOVA: P<0.001) and insulin (ANOVA: P<0.01) were significantly higher in diabetic animals compared with lean animals, independent of treatment regimen. For body weight, the interaction between genotype and treatment was significant and a pairwise analysis of differences is provided by Bonferroni-corrected two-sided unpaired t-tests: <sup>##</sup> P<0.01, <sup>###</sup> P<0.001 when compared with lean animals of the same treatment regimen.</p
<p>Data is represented as mean ± SD (n = 6 per group). For the RCR with pyruvate, the interaction be...
Background: Metformin was approved by FDA in 1994 for the treatment of type II diabetes mellitus. Du...
<p>Values are mean ± SE of glucose blood levels weekly measured in diabetic (D) and RSV-treated diab...
<p>Data is represented as mean ± SD (n = 6 per group). At rest, pH was significantly lower and [Pi] ...
<p>ZDF rats were hyperglycemic in the fed state at 8 and 10 weeks of age, but measurements were high...
<p>a) The diabetic rats exhibited greater fluid intake than the non-diabetic rats throughout the exp...
<p>Before and after the 14-day treatment period, the body weights (A) and plasma glucose levels (B) ...
<p>(A) Body weight curves for Wistar rats fed on a standard rodent chow diet (control) or a high-fat...
<p>ZL: normal Zucker lean rats, ZDF: vehicle-treated Zucker diabetic fatty rats, KIOM-79: Zucker dia...
<p>(A) OGTT in diabetic ZDF rat (▪, black squares), normal ZLC rats (□, white squares), rosiglitazon...
<p>(A) Glucose profile in IPGTT (glucose 2g/kg) before treatment (B) Glucose profile in IPGTT (gluco...
<p>Animal characteristic in control and diabetic Ren-2 rats treated with and without FT011. Data are...
<p>All results are mean ±SEM. Significant differences between controls (n = 7), diabetic (n = 10) an...
<p>N = 6. <sup>a</sup>p<0.001 versus NP. ANOVA with Bonferroni post-hoc indicated significant differ...
Pathophysiological investigation of disease in a suitable animal model is a classical approach towar...
<p>Data is represented as mean ± SD (n = 6 per group). For the RCR with pyruvate, the interaction be...
Background: Metformin was approved by FDA in 1994 for the treatment of type II diabetes mellitus. Du...
<p>Values are mean ± SE of glucose blood levels weekly measured in diabetic (D) and RSV-treated diab...
<p>Data is represented as mean ± SD (n = 6 per group). At rest, pH was significantly lower and [Pi] ...
<p>ZDF rats were hyperglycemic in the fed state at 8 and 10 weeks of age, but measurements were high...
<p>a) The diabetic rats exhibited greater fluid intake than the non-diabetic rats throughout the exp...
<p>Before and after the 14-day treatment period, the body weights (A) and plasma glucose levels (B) ...
<p>(A) Body weight curves for Wistar rats fed on a standard rodent chow diet (control) or a high-fat...
<p>ZL: normal Zucker lean rats, ZDF: vehicle-treated Zucker diabetic fatty rats, KIOM-79: Zucker dia...
<p>(A) OGTT in diabetic ZDF rat (▪, black squares), normal ZLC rats (□, white squares), rosiglitazon...
<p>(A) Glucose profile in IPGTT (glucose 2g/kg) before treatment (B) Glucose profile in IPGTT (gluco...
<p>Animal characteristic in control and diabetic Ren-2 rats treated with and without FT011. Data are...
<p>All results are mean ±SEM. Significant differences between controls (n = 7), diabetic (n = 10) an...
<p>N = 6. <sup>a</sup>p<0.001 versus NP. ANOVA with Bonferroni post-hoc indicated significant differ...
Pathophysiological investigation of disease in a suitable animal model is a classical approach towar...
<p>Data is represented as mean ± SD (n = 6 per group). For the RCR with pyruvate, the interaction be...
Background: Metformin was approved by FDA in 1994 for the treatment of type II diabetes mellitus. Du...
<p>Values are mean ± SE of glucose blood levels weekly measured in diabetic (D) and RSV-treated diab...